Sarah Mennenga

Dr. Sarah Mennenga is a Research Assistant Professor at Arizona State University's School of Life Sciences, specializing in behavioral neuroscience and psychedelic medicine. She holds a BS, MA, and PhD from Arizona State University (2010-2015), followed by a postdoctoral fellowship at NYU Langone's Center for Psychedelic Medicine (2020). Her work focuses on psilocybin-assisted psychotherapy for mood, anxiety, and substance use disorders, and she contributed to foundational clinical trials establishing psilocybin's safety and efficacy in psychiatry. Dr. Mennenga is a recognized expert in neuroendocrinology and cross-species translational research, particularly exploring hormonal influences on mental health and bridging rodent models to human clinical research.

Her research interests include neurobiological mechanisms of addiction, hormonal modulation of mental health outcomes, and the implementation of Schedule I drug trials. She has authored over 10 peer-reviewed manuscripts on psychedelic therapies and holds expertise in neuroendocrine pathways linking stress hormones to brain structure/function. Key collaborations include work with Drs. Michael Bogenschutz and Stephen Ross at NYU Langone, advancing psychedelic medicine into mainstream clinical practice.

Dr. Mennenga's recent publications (2020-2025) highlight psilocybin's impact on alcohol use disorder, cancer-related distress, and pediatric neurodevelopment. Her work emphasizes translational research rigor, ethical clinical trial design, and bridging preclinical findings to human applications. Awards and recognitions are pending explicit mentions in provided texts.